CHRISTIE BALLANTYNE to Injections, Subcutaneous
This is a "connection" page, showing publications CHRISTIE BALLANTYNE has written about Injections, Subcutaneous.
Connection Strength
0.293
-
Results of bococizumab, a monoclonal antibody against proprotein convertase subtilisin/kexin type 9, from a randomized, placebo-controlled, dose-ranging study in statin-treated subjects with hypercholesterolemia. Am J Cardiol. 2015 May 01; 115(9):1212-21.
Score: 0.121
-
Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia. N Engl J Med. 2024 Sep 12; 391(10):913-925.
Score: 0.057
-
Relative contribution of LFA-1 and Mac-1 to neutrophil adhesion and migration. J Immunol. 1999 Nov 01; 163(9):5029-38.
Score: 0.042
-
Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS). Eur Heart J. 2018 10 07; 39(38):3499-3507.
Score: 0.039
-
Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial. JAMA. 2016 12 13; 316(22):2373-2384.
Score: 0.034